MedDataX Logo

Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer

NCT ID: NCT01832246

Last Updated: 2014-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

560 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The accurate prediction of depth of tumor invasion in early gastric cancer is essential for the proper selection of candidates for endoscopic resection. Conventional endoscopy and endoscopic ultrasonography have been useful diagnostic method for depth of invasion in early gastric cancer. However, there has been no prospective comparative study on the accuracy between the 2 methods. Therefore, the investigators prospectively compare the accuracy between the 2 methods regarding prediction of depth of invasion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Tumor Early Gastric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with early gastric adenocarcinoma undergo both endoscopic staging and endoscopic ultrasonographic staging for depth of invasion

Exclusion Criteria

* patients had previously received neoadjuvant chemotherapy or chemoradiotherapy
* patients with obviously advanced gastric cancer by endoscopy
* the evidence of distant metastasis or extensive adjacent organ invasion on abdominal CT scan
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jeongmin Choi

professor, Department of Internal Medicine and Liver Research Institute

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sang Gyun Kim, M.D.

Role: STUDY_DIRECTOR

Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine

Jeongmin Choi, M.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Division of Gastroenterology, Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital

Seoul, Seoul, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jeongmin Choi, M.D.

Role: CONTACT

[email protected]
82-2-2072-7209

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jeongmin Choi, M.D.

Role: primary

[email protected]
82-2-2072-7209

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20122012

Identifier Type: -

Identifier Source: org_study_id